CYP19A1 and ablepharon macrostomia syndrome: Based on the evidence described above for CMS and our observations, it may be possible to regulate the T/E2 ratio by increasing the aromatization of T into E2, increasing aromatase expression or even applying E2 exogenously to prevent and treat AMS.